28th July 2025 The Company wishes to reiterate that the commercial transaction, along with all relevant details regarding the parties involved, will be announced on Friday, 1st August 2025. We acknowledge that Johnson & Johnson has never entered into or expressed an intent to enter into a transaction or relationship… Read more
24th July 2025 The Company is aware of recent statements regarding the DaaP sale, which it firmly challenges. We wish to reassure all stakeholders that the commercial transactions are progressing as expected. A full announcement confirming the DaaP sale, along with details of the buyers and third parties involved, will… Read more
14th July 2025 Cloudtag is pleased to confirm a significant and positive step forward in the completion of the transaction process, as first outlined in our 24th June 2025 update. We are delighted to announce the formal appointment of a highly experienced, independent US-based lawyer as Transaction Agent, who has… Read more
Cloudtag Inc CEO Amit Ben-Haim provides an exclusive update to DirectorsTalk about its plans for 2018. Amit explains how the company has consolidated the Company’s position and focus on the B2B space, how the transition from B2C to B2B has kicked off the engagement process with Insurance companies, Health Care… Read More
